Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Hippocampal malrotation (HIMAL) is an increasingly recognized neuroimaging feature but the clinical correlation and significance in epilepsies remain under debate. It is characterized by rounded hippocampal shape, deep collateral, or occipitotemporal sulcus, and medial localization of the hippocampus. In this review, we describe the embryonic development of the hippocampus and HIMAL, the qualitative and quantitative diagnosis issues, and the pathological findings of HIMAL. HIMAL can be bilateral or unilateral and more on the left side. Furthermore, the relevance of HIMAL diagnosis in clinical practice, including its role in epileptogenesis and the impact on the pre-surgical decision are reviewed. Finally, the relationship between HIMAL and hippocampal sclerosis (HS) and the possible role of genetics in the etiology of HIMAL are discussed. The evidence so far suggested that HIMAL does not have a significant role in epileptogenesis or surgical decision. HIMAL could be a genetic developmental imaging feature that represents a more diffuse but subtle structural error during brain development. Many questions remain to be explored, such as possible cognitive alteration associated with HIMAL and whether HIMAL predisposes to the development of HS. Further studies using high-quality MRI, unified consensus qualitative and quantitative diagnostic criteria, and comprehensive cognitive assessment are recommended.

Details

Title
Hippocampal Malrotation: A Genetic Developmental Anomaly Related to Epilepsy?
Author
Ting-Ying, Fu 1 ; Chen-Rui, Ho 2   VIAFID ORCID Logo  ; Lin, Chih-Hsiang 2 ; Yan-Ting, Lu 2 ; Wei-Che, Lin 3 ; Meng-Han, Tsai 4   VIAFID ORCID Logo 

 Department of Pathology, Yuan’s General Hospital, 162 Cheng Hung 1st Road, Kaohsiung 80249, Taiwan; [email protected] 
 Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Niaosung District, Kaohsiung 83301, Taiwan; [email protected] (C.-R.H.); [email protected] (C.-H.L.); [email protected] (Y.-T.L.) 
 Department of Radiology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan; [email protected] 
 Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, 123 Dapi Road, Niaosung District, Kaohsiung 83301, Taiwan; [email protected] (C.-R.H.); [email protected] (C.-H.L.); [email protected] (Y.-T.L.); School of Medicine, Chang Gung University, 259 Wenhau 1st Road, Taoyuan 33302, Taiwan 
First page
463
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20763425
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2528297797
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.